You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

SOLU-MEDROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Solu-medrol patents expire, and when can generic versions of Solu-medrol launch?

Solu-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in SOLU-MEDROL is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SOLU-MEDROL?
  • What are the global sales for SOLU-MEDROL?
  • What is Average Wholesale Price for SOLU-MEDROL?
Summary for SOLU-MEDROL
Drug patent expirations by year for SOLU-MEDROL
Drug Prices for SOLU-MEDROL

See drug prices for SOLU-MEDROL

Drug Sales Revenue Trends for SOLU-MEDROL

See drug sales revenues for SOLU-MEDROL

Recent Clinical Trials for SOLU-MEDROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zheng LiuN/A
Brii Biosciences LimitedPhase 2
Emory UniversityPhase 4

See all SOLU-MEDROL clinical trials

Pharmacology for SOLU-MEDROL

US Patents and Regulatory Information for SOLU-MEDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-006 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-007 Feb 27, 1985 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.